These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2073 related articles for article (PubMed ID: 28629431)

  • 1. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer.
    Wei C; Zhang R; Cai Q; Gao X; Tong F; Dong J; Hu Y; Wu G; Dong X
    Aging (Albany NY); 2019 Sep; 11(17):6734-6761. PubMed ID: 31498117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M; Liao X; Li L; Li G; Chen M
    Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
    Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
    Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
    Zeng X; Liu D; Peng G; Liu J; Yang H
    Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX; Zhou KC; Cao Y
    Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
    Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
    Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p.
    Jing H; Xia H; Qian M; Lv X
    Biomed Pharmacother; 2019 Feb; 110():825-833. PubMed ID: 30554121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
    Li X; Zheng H
    Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
    Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
    Geng Q; Li Z; Li X; Wu Y; Chen N
    J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
    Qi G; Li L
    Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
    Fan JM; Zheng ZR; Zeng YM; Chen XY
    Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 104.